ePosters - Irish Thoracic Society

Reset

ID	Poster title	Author(s)	Institution	Category
					View
1.22	Home Sleep Apnoea Testing: Optimising Patient Outcome with Limited Resources	Orla Wynne	Tallaght University Hospital	Asthma & Sleep	View
1.1	Severe Asthma Service Naas General Hospital	Barbara Loughman	Naas General Hospital	Asthma & Sleep	View
1.01	Clinical accuracy and risk of harm in asthma related content on TikTok	Emma McNally	St James Hospital	Asthma & Sleep	View
1.13	The Introduction of Improved Quality Assurance Practices in a Sleep Laboratory	Rachel Anglin	St Vincent's University Hospital	Asthma & Sleep	View
1.14	The impact of Multiple Sleep Latency Testing (MSLT) as an additional diagnostic tool to assess central disorders of hypersomnia at Connolly Hospital Sleep Disorders Unit	Emanuela Costin	Connolly Hospital	Asthma & Sleep	View
1.1	The efficacy of Elexacaftor/Tezacaftor/Ivacaftor in patients with cystic fibrosis and advanced lung disease	O.M. O'Carroll K.M.O'Shea C.Carroll B. Grogan A.Connolly L. O'Shaughnessy T. Nicholson C.G. Gallagher E.F. McKone	National Referral Centre for Adult Cystic Fibrosis, St. Vincent’s University Hospital, Dublin 4, Ireland.	Lung Cancer/CF/ILD/Surgery	View
1.01	Don’t act on the ACT	Vincent Brennan	RCSI	Asthma	View
1.15	Outcomes in at home pulse oximetry in a paediatric respiratory centre	Jason Foran	University Hospital Limerick	Asthma & Sleep	View
1.16	A review of the use of domiciliary non-invasive ventilation in a tertiary hospital	Margaret Higgins	St. Vincent's University Hospital	Asthma & Sleep	View
1	Protected: Digital Ischaemia in Anti-Synthetase Syndrome	M. Lincoln W. Binalialsharabi P. Nadarajan	St James's Hospital		View
1.17	Liraglutide-Based Weight Loss versus CPAP Therapy in improving Sleep Quality and Quality of Life of Patients with Obstructive Sleep Apnoea – an Explorative, Proof of Concept Study	Cliona O'Donnell	St. Vincent's University Hospital	Asthma & Sleep	View
1.18	Are we doing the necessary investigations to monitor for cardiometabolic risk factors in confirmed cases of obstructive sleep apnoea in our centre?	Aoife Power	Tallaght University Hospital	Asthma & Sleep	View
1.19	Management and Outcomes of Mild OSA (AHI 5-15): A Real-World Study	Romina Golchin	University College Cork	Asthma & Sleep	View
1.2	The Effect of Sleep on Successful Weight Loss Following Bariatric Surgery	Sonia Jermyn	University College Cork	Asthma & Sleep	View
1.21	Non-CPAP therapies in the treatment of Obstructive Sleep Apnoea	Ciara McLoughlin	Bons Secours Hospital Cork	Asthma & Sleep	View
1.01	Evaluation of 116 Patients with IPF commenced on anti-fibrotic treatment therapies in Cork University Hospital	B.Bowen M.Henry	Cork University Hospital	ILD	View
1.02	Respiratory Bronchiolitis Interstitial Lung Disease – is it more common than we thought?	C Cruickshank, M Donaghy, E Murtagh, P Minnis.	Northern Trust Antrim Area Hospital Interstitial Lung Disease Service, Northern Ireland	ILD	View
1.03	Type II alveolar epithelial cell dysfunction associates with altered iron levels after bleomycin treatment	Sarah Kenny1*, Ziling Huang 2,3 and Suzanne M. Cloonan1,2.	Trinity College Dublin	ILD	View
1.04	Mode of Presentation, Diagnosis and Prevalence of Lymphangioleiomyomatosis in an Irish population	E Lynn M O’Callaghan L Browne M.P. Keane C McCarthy	St. Vincent's University Hospital	ILD	View
1.05	Computed Tomography morphometric analysis of patients with Idiopathic Inflammatory Myopathy related Interstitial Lung Disease correlates with Forced Vital Capacity	O’Mahony A1, Henry P3, Coughlan P2, Crowley C1, Ryan D1, Moore N1, O’Connor OJ1, Maher M1, Henry MT2 1. Academic Department of Radiology, Cork University Hospital / University College Cork 2. Department of Respiratory Medicine, Cork University Hospital / University College Cork 3. School of Medicine, University College Cork	CUH/UCC	ILD	View
1.06	Hypercalcaemia in patients with sarcoidosis in the South of Ireland	JL O’Sullivan, LJ Walsh, HI Ibrahim, TM O’Connor	Mercy University Hospital Cork, Ireland	ILD	View
1.07	Accessory muscles support respiratory system performance in young dystrophin-deficient mdx mice	AD Slyne KD O'Halloran DP Burns	University College Cork	Miscellaneous	View
1.09	The development of a point of care test for the quantitative determination of active neutrophil elastase in sputum	McCafferty D Raj S Johnston S Lubarsky G McLaughlin J	ProAxsis Ltd and Northern Ireland Connected Health Innovation Centre (CHIC)	Miscellaneous	View
1.1	Characteristics of Sarcoid Associated Pulmonary Hypertension in Ireland	M Higgins S Cullivan B McCullagh S Gaine	Mater Misericordiae University Hospital	Miscellaneous	View
1.11	Initial experience of virtual pulmonary rehabilitation in a district general hospitalin a	R McGarrigle, R.Sharkey	Western Health & Social Care Trust	Miscellaneous	View
1.12	Transitioning Between Oral And Parenteral Prostacyclin Therapy In Two Patients With Idiopathic Pulmonary Arterial Hypertension	S Devlin (first author) S Cullivan B McCullagh SP Gaine	National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital	Miscellaneous	View
1.13	A single center audit of access to healthcare and disease monitoring in patients diagnosed with Idiopathic pulmonary fibrosis.	L Carey S Comerford H Mulryan S Walsh A O' Regan	University Hospital Galway	ILD	View
1.14	Survey of idiopathic pulmonary fibrosis (IPF) patients who participated in online group exercise classes to facilitate physical activity during Covid-19 pandemic.	Gordon Cagney; Niamh Julian; Paula Ryan; Aiden O’Brien; Brian Casserly; Gemma O’Dowd; Nicola Cassidy; Danny Sheahan.	University Hospital Limerick, Irish Lung Fibrosis Association, Invisio Ltd.	ILD	View
1.15	The Irish Lung Fibrosis Association’s Multi-Stakeholder World Café on Pulmonary Fibrosis Services in Ireland During Covid-19 and Beyond	N Cassidy E Judge G O’Dowd T Shone AM Russell	Irish Lung Fibrosis Association	ILD	View
1.16	Lung fibrosis patients identify deficiencies in vital healthcare support services	N Cassidy L Fox L Brown L Galvin G O’Dowd D Sheahan K O’Reilly	Irish Lung Fibrosis Association	ILD	View
1.17	Scleroderoma-related ILD	D Doyle M Henry	Cork University Hospital	ILD	View
1.19	Compliance with ATS/ERS guidelines for lung fibrosis reporting in CT thorax in University Hospital Kerry, and demographic distribution of pulmonary fibrosis in Kerry Group	A.Nabri, M.I.Khan, U.Khan, H.Arshad	University Hospital Kerry	ILD	View
1.2	The correlation of ILD MDT diagnosis with explant histopathology in transplant recipients.	D O’Malley, M O’Callaghan, L Brown, A Fabre, MP Keane, C McCarthy	St Vincents University Hospital	ILD	View
1.21	The impact of virtual pulmonary rehabilitation programme on physical activity on people with idiopathic pulmonary fibrosis: a feasibility study	O O.’Shea, G. Murphy, L. Forde, G. Casey, L. Fox, K.M.A. O’Reilly	RCSI and Mater University Hospital	ILD	View
1.22	Interstitial Lung Disease Acute Exacerbation Audit within the COVID-19 Pandemic	DBarry S Toland K Hurley	Beaumont Hospital , Dublin	ILD	View
1.23	Investigating mucosal associated invariant T (MAIT) cells in lymphangioleiomyomatosis (LAM)	S. Boyle A. Hogan A. Jouida MP. Keane C. McCarthy	University College Dublin	ILD	View
1.25	A Two Year Review Of Anti-Fibrotic Medication For the Treatment of Idopathic Pulmonary Fibrosis In St James’s Hospital	R Kennedy, L Dolan, C Gray, K Devenney, P Nadarajan	St James's Hospital	ILD	View
1.26	PCP Prophylaxis in Patients with Interstitial Lung Disease (ILD) on Steroids And/or other Immunosuppressive Medication	M. O’Callaghan Y. Ibrahim L. Fox J. Stack K.MA. O’Reilly	Mater Misericordiae University Hospital	ILD	View
1.28	Audit of Thoracic Activity in Level 1 Trauma Centre	Tanya Chandwani, Nida Ara, Daniyal Arshad, Mr Nadeem Anjum, Mr Kishore Doddakula	Cork University Hospital	Lung Cancer and Bronchoscopy	View
1.29	An Audit on the Baseline Extra-Pulmonary Screening Investigations of Biopsy-Confirmed Sarcoidosis Patients in Mater Misericoardiae University Hospital	A Asis D Halim N Boyle A Kirk T McEnery	Mater Misericordiae University Hospital	Miscellaneous	View
1.3	Current Physiotherapy knowledge of temporary Tracheostomies in St. Luke’s General Hospital, Kilkenny	KDowling	St. Luke's hospital Kilkenny	Miscellaneous	View
1.31	A retrospective analysis of the current management and investigation of pleural infections at the Royal Victoria Hospital Belfast from 1/2/21-31/1/21	C Eastwood P Nelson M Hunter CA Butler	Department of respiratory medicine at the Royal Victoria Hospital. Belfast Health and Social care Trust Northern Ireland	Miscellaneous	View
1.32	Pulmonary function test ordering practices in the COVID-19 era – a clinical audit at Beaumont Hospital	S Garvey, E Mullen, L Clarke, ME O’Brien	Beaumont Hospital	Miscellaneous	View
1.33	A Clinical Audit on the Use of Respiratory Physiotherapy Outcome Measures on Inpatients in St. Luke’s General Hospital	E. Geraghty	St. Luke's General Hospital Carlow/Kilkenny	Miscellaneous	View
1.34	Improving the assessment, prescription and follow up of inpatients newly commenced on home oxygen in an acute hospital	C. Gleeson C. Gray P. Nadarajan	St. James’s Hospital, Dublin 8.	Miscellaneous	View
1.35	Impact On Hospital Length of Stay of A Respiratory Assessment Unit	C. Hayes, S. Toland, L. Madden-Doyle, R. Morgan, E. O’Brien.	Beaumont Hospital, Dublin	Miscellaneous	View
1.36	Improving Awareness of Monitoring and Education of Patients Prescribed Methotrexate in Respiratory Care	S Burke, A Shahid, R Minogue, K Cooper, K Finan	Sligo University Hospital	Miscellaneous	View
1.37	‘Is O2 too much of a go to?’ An audit into our practice.	A. Sheehan	St. Lukes Hospital Kilkenny	Miscellaneous	View
1.38	Establishment of a Tertiary Care Respiratory Assessment Unit	S Toland L Power C Hayes K Hurley RK Morgan ME O'Brien	Beaumont Hospital	Miscellaneous	View
1.39	An Integrated Respiratory Service- from paper to patient and beyond	A Barry R Reilly SDW Miller	Our Lady's Hospital, Navan, Co. Meath	Miscellaneous	View
1.4	A Survey Of The Use Of High Flow Nasal Oxygen in Cork University Hospital	S Healy AM Fitzgerald M O'Grady A Hallahan MT Henry DM Murphy	Cork University Hospital	Miscellaneous	View
1.41	“It is the fear of exercise that stops me” – Attitudes and dimensions influencing physical activity in pulmonary hypertension patients	C McCormack, Dr. B Furlong, S Cullivan, Dr. N McCaffrey, Prof. S Gaine, Dr. B McCullagh, Prof. N.M Moyna1, Dr. SJ. Hardcastle	Dublin City University	Miscellaneous	View
1.42	A composite tissue-engineered biomaterial scaffold with refined mechanical properties and vascularisation for tracheal regeneration	T Khalid M Lemoine SA Cryan FJ O’Brien C O’Leary	Royal College of Surgeons in Ireland	Miscellaneous	View
2.2	Perceptions and knowledge of lung volume reduction procedures for chronic obstructive pulmonary disease in the Republic of Ireland: a survey of respiratory healthcare professionals	Daire Plunkett	Mater Misericordiae University Hospital, Eccles Street, Dublin 7	COPD	View
2.1	Does an information talk prior to Pulmonary Rehabilitation improve completion rate?	Clodagh O'Meara	Dublin North West Integrated Care Centre	COPD	View
2.21	Effectiveness of COPD Support Ireland-delivered exercise classes in maintaining symptoms and functional status	Joan Johnston	COPD Support Ireland	COPD	View
2.11	Can Pulmonary Rehabilitation (PR) Resolve Sarcopenia in patients with Chronic Lung Disease?	Catherine Speirs	Ballinasloe Chronic Disease Hub	COPD	View
1.02	The role of FENO in the diagnosis of asthma	Harisanjiv Rajendram	Bon Secours Hospital, Cork	Asthma & Sleep	View
2.01	Establishing Diurnal Variation of Inflammatory Markers in Genetic COPD	Lameese Alhaddah	RCSI	COPD	View
2.12	An Audit on Compliance with COPD Guidelines in Midlands Regional Hospital, Tullamore	Eleanor Cronin	Midlands Regional Hospital, Tullamore	COPD	View
2.02	Serum Eosinophils in Patients with Chronic Obstructive Pulmonary Disease (COPD) Attending Our Lady of Lourdes Hospital (OLOL)	Arsah Asis	Our Lady of Lourdes Hospital, Drogheda	COPD	View
2.13	How pulmonary rehabilitation influences Frailty as measured using the Clinical Frailty Scale (CFS)	Niamh Duignan	HSE Galway city integrated care hub	COPD	View
1.2	Impact of Covid-19 on pulmonary fibrosis patients, carers and healthcare professionals and future advocacy priorities.	N Cassidy L Fox L Brown L Galvin K O’Reilly	Irish Lung Fibrosis Association	COVID-19	View
2.03	What effect does home-based management have on COPD patients’ hospital & readmission rates	Rita Corcoran	CHW Mayo, HSE	COPD	View
2.14	A new initiative: Progressive Resistance Training (PRT) in patients with Chronic Obstructive Pulmonary Disease (COPD) in Pulmonary Rehabilitation (PR) exercise class	Rachel Egan	Tallaght University Hospital	COPD	View
1.02	Inflammatory pathways in severe asthma	Vincent Brennan	RCSI	Asthma	View
2.04	Carbon Emissions, Sedentary Travel Time and Mode of Transport to a Community-Based Multi-Site Pulmonary Rehab Program	Sinéad Delahunty	South Tipperary Community Specialist Respiratory Team, Integrated Care Programme for Chronic Disease, HSE	COPD	View
2.15	Alpha-1 Antitrypsin Deficiency: Evaluating the Effectiveness of Health-Related Quality of Life Data in Tracking Disease Severity and Progression	Mariam Ghoneem	Royal College of Surgeons in Irealnd	COPD	View
2.05	Pre and Post Pandemic Exercise Capacity and Symptom Burden in Chronic Obstructive Pulmonary Disease	Elizabeth Dunphy	St Michael's Hospital, Dun Laoghaire	COPD	View
2.16	Don’t ignore the nonsense: Alpha-1 Antitrypsin Deficiency caused by null mutations	Ronan Heeney	RCSI	COPD	View
2	Protected: A Case of Cryptococcus Pericarditis in a Lung Transplant Recipient	N Boyle, S Winward, I Lawrie, S Towell, J Egan, N Ronan, M Murray.	The National Heart and Lung Transplant Centre, Mater Misericordiae University Hospital, Dublin.		View
2.06	Mapping behaviour change interventions for physical activity behaviour in chronic obstructive pulmonary disease to the Theoretical Domains Framework: a systematic review and meta-analysis	Ciara Hanrahan	University College Cork	COPD	View
2.17	Implementation of Azithromycin Prophylaxis Guidance in Our Lady of Lourdes Hospital, Drogheda	Viji Mathew	Our Lady of Lourdes Hospital	COPD	View
2.07	A review of Azithromycin Prophylaxis; Appropriateness of Initial Prescription and Safety Monitoring	Daphne Masterson	ICPCD, South Tipperary	COPD	View
2.18	Exploring Metal-Derived Therapeutics For Combating COPD Exacerbations	Megan O'Shaughnessy	Trinity College Dublin	COPD	View
2.08	Steroid Prescribing Practices in Acute COPD Exacerbations– An Audit of a Level 3 Irish Hospital	Mary Mc Namee	St Vincent's University Hospital, Elm Park	COPD	View
2.19	Physical Activity, Exercise Capacity and Sedentary Behaviour in People with Alpha-1 Antitrypsin Deficiency: A Scoping Review	Orlagh O'Shea	RCSI	COPD	View
2.09	A Micro-Costing Analysis of Lung Volume Reduction Surgery from a National Tertiary Referral Centre	Kathryn Mulryan	Mater Hospital	COPD	View
2.01	Real world Experience of Single Use Flexible Bronchoscopy over Six Months in a Tertiary Centre	Anne-Marie Sweeney Grace Kavanagh Patrick Coghlan Hammad Danish Fernando Gomez Barry Plant Michael Henry Marcus Peter Kennedy	Department of Respiratory Medicine, Cork University Hospital	Lung Cancer and Bronchoscopy	View
2.02	Lung Cancer Detection During COVID-19 Pandemic	D. Halim S. Foley A. Asis CR. Cayabyab C. Higgins F. Colhoun D. Burnell RK. Morgan ME. O’Brien	Department of Respiratory Medicine, Beaumont Hospital	Lung Cancer and Bronchoscopy	View
2.03	Accuracy of Multidisciplinary Team Consensus for Lung Cancer Resection in the absence of pre-operative histology: A five-year experience.	J Whooley R Weedle A White D Breen A Soo	University Hospital Galway	Lung Cancer and Bronchoscopy	View
2.05	Dedicated Lung Nodule Services Reduces Need for Follow up Imaging	Walsh S, Cogan G, Counihan I, Quinn A, Hassan T	Our Lady Of Lourdes Hospital, Drogheda, Co. Louth	Lung Cancer and Bronchoscopy	View
2.06	An Audit of Endobronchial Ultrasound Services for Detection of Lung Cancer in University Hospital Galway 2020	N Hyland, D Doyle, D Breen	University Hospital Galway	Lung Cancer and Bronchoscopy	View
2.07	Impact of Elexacaftor/Tezacaftor/Ivacaftor on airway inflammation and clinical outcomes in Patients with Cystic Fibrosis.	M.Casey C.Gabillard-Lefort O.Kerr E.Marron AM.Lyons L.Cullen A.Murphy C.Gunaratnam EP.Reeves NG.McElvaney	1 The Irish Centre of Genetic Lung Disease, Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland 2 Cystic Fibrosis Unit, Department of Respiratory Medicine, Beaumont Hospital, Dublin, Ireland	CF and Pulmonary Infections	View
2.08	Pre-Activated Umbilical Cord Derived Mesenchymal Stromal Cells Enhance the Restoration of Local and Systemic Immune Homeostasis During Transitionary Phase Pulmonary Sepsis	D. Byrnes C. Masterson H. Gonzalez S. McCarthy D. O'Toole J. Laffey	National University of Ireland, Galway	CF and Pulmonary Infections	View
2.09	Differential Gene Expression in the Immunometabolic Response of Human Macrophages in tuberculosis and HIV infection.	K Brown M O'Sullivan S O'Leary J Keane	TTMI, St. James' Hospital	CF and Pulmonary Infections	View
2.1	Primed Human Bone Marrow Mesenchymal Stromal Cells as a Therapeutic Strategy for Klebsiella Pneumonia	CH Masterson D Byrnes H Gonzalez SD McCarthy DP O'Toole JG Laffey	National University of Ireland, Galway	CF and Pulmonary Infections	View
2.11	PREDICTORS FOR CHOICE OF DIRECTLY OBSERVED THERAPY IN PATIENTS WITH TUBERCULOSIS IN THE SOUTH OF IRELAND	A. McDonagh L. Walsh H. Ibrahim T. O'Connor	Mercy University Hospital, Cork, Ireland. University College Cork, Ireland.	CF and Pulmonary Infections	View
2.12	Dexamethasone Reduces Metabolic Function and Subsequent Activation of Human Macrophages to Mycobacterium tuberculosis.	L Thong DJ Cox J Keane	TTMI, Trinity College Dublin	CF and Pulmonary Infections	View
2.13	Proteomic Analysis Of The Nanoparticle Biomolecular Corona Formed In The Plasma Of Lung Cancer Patients And Healthy Controls	I Marinescu ND Trinh MP Keane M Monopoli C McCarthy	UCD and St Vincent's University Hospital, RCSI	Lung Cancer and Bronchoscopy	View
2.14	Bronchoscopy Training using ALFIETM (Airway Low-Fidelity including Endobronchial Ultrasound Bio-simulator) and Single Use Flexible Bronchoscopy	KF Deasy AM Sweeney BA O'Reilly MP Kennedy	Department of Respiratory Medicine, Cork University Hospital	Lung Cancer and Bronchoscopy	View
2.15	Is High Dependancy Unit mandatory for all lung resections	Daniyal Arshad, Tanya Chandwani, Nida Ara, Mr Nadeem Anjum, Mr Kishore Doddakula	Cork University Hospital	Lung Cancer and Bronchoscopy	View
2.17	Early-stage lung cancer presents incidentally. Is it time for a national lung cancer screening program?	R. Keane G. Cogan I. Counihan	Respiratory Department, Our Lady of Lourdes Hospital, Drogheda, Co. Louth, Ireland	Lung Cancer and Bronchoscopy	View
2.18	Is Robotic Lobectomy Cheaper? A Micro – Cost Analysis	B Shanahan U Kreaden J Sorensen K Redmond	Royal College of Surgeons in Ireland	Lung Cancer and Bronchoscopy	View
2.19	10-YEAR RETROSPECTIVE DATA ON NON-SMALL CELL LUNG CANCER (NSCLC): NO IMPROVEMENT IN EARLY DETECTION	SW. Tio A. O’Mahony P. Coghlan D. Curran TM. O’Connor	Mercy University Hospital	Lung Cancer and Bronchoscopy	View
2.2	A review of complications post CT guided lung biopsies in the Mid-Western Lung Cancer Centre	MK Rana G Bennett B Okpaje S Shahsavari A Farrell P Hession A O’Brien	University Hospital Limerick	Lung Cancer and Bronchoscopy	View
2.21	Audit of Satisfaction levels amongst patients who had thoracic surgery during the first surge of Covid 19	M Kingston G Fitzmaurice A Gonzales R Shanahan	St James's Hospital	COVID 19	View
2.22	Meeting Quality Standards in Endobronchial Ultrasound	N Smyth, M Kelly, C King	Altnagelvin Hospital	Lung Cancer and Bronchoscopy	View
2.23	Single Use Flexible Bronchoscopy: An ex-vivo comparison of all commercially available scopes	KF Deasy AM Sweeney EM O'Reilly MP Kennedy	Department of Respiratory Medicine, Cork University Hospital	Lung Cancer and Bronchoscopy	View

1 2 … 7 8 »